Business
Montec Holdings Inc. obtains conditional approval of the TSX Venture Exchange in connection with the extension of the expiry date of warrants
MONTREAL, Dec. 24 /CNW Telbec/ - Montec Holdings Inc. ("Montec" or the "Company") (TSX-V : MTE), ...
About this update from Defence Therapeutics Inc Class A
[{"type":"text","content":"\n\n\n\nMONTREAL, Dec. 24 /CNW Telbec/ - Montec Holdings Inc. ("Montec" or the\n"Company") (TSX-V : MTE), a holding company focused on acquiring and\ndeveloping a diversified portfolio of high-growth technology companies is\npleased to announce that it has the conditional approval of the TSX Venture\nExchange in connection with extension of the expiry date of 3,450,000 warrants\nto purchase 3,450,000 common shares having an exercise price of $0.25 per\ncommon share from December 29, 2008 to December 29, 2010.\n\n\nAbout Montec Holdings Inc.\n\n\nMontec Holdings Inc. is listed on the TSX Venture Exchange (TSX-V: MTE).\nMontec's objective is to create shareholder value by building a profitable\ntechnology entity with high-growth potential. Structured as a holding company,\nMontec's mandate is to acquire shareholdings of a number of synergistic\ncompanies and develop a diversified portfolio of high-growth technology\ncompanies. For more information about Montec Holdings, please visit our\nwebsite at www.montecholdings.com\n\n\nForward Looking Statements\n\n\nThis press release contains forward-looking statements which reflect the\nCompany's current expectations regarding future events. The forward-looking\nstatements involve risks and uncertainties. Actual results could differ\nmaterially from those projected herein. The Company disclaims any obligation\nto update these forward-looking statements.\n\n\nThe TSX Venture Exchange Inc. has not reviewed and does not accept\n\n\nresponsibility for the adequacy or accuracy of this release.\n\n\n%SEDAR: 00020865EF\n\n\n","length":1660,"tagName":"div"}]